-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Assumes Amgen at Buy, Raises Price Target to $380

Benzinga·01/07/2026 13:25:53
Listen to the news
UBS analyst Michael Yee assumes Amgen (NASDAQ:AMGN) with a Buy rating and raises Price Target to $380.